Cited by 27Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic SkillsPolyomavirus and related diseases

Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes

Martinelli, V., Dalla Costa, G., Messina, M. J., Di Maggio, G., Sangalli, F., Moiola, L., Rodegher, M., Colombo, B. +4 more·2017·Acta Neurologica Scandinavica

Abstract

Objectives Since its introduction, MRI had a major impact on the early and more precise diagnosis of multiple sclerosis (MS), and the 2010 diagnostic criteria even allow a diagnosis to be made just after a single attack if stringent MRI criteria are met. Several other clinical and paraclinical markers have been reported to be associated with an increased risk of MS independently of MRI in patients with clinically isolated syndromes (CIS), but the incremental usefulness of adding them to the current criteria has not been evaluated. In this study, we determined whether multiple biomarkers improved the prediction of MS in patients with CIS in a real-world clinical practice. Materials and methods This was a retrospective study involving patients with CIS admitted to our department between 2000 and 2013. We evaluated baseline clinical, MRI, neurophysiological, and cerebrospinal fluid (CSF) data. Results During follow-up (median, 7.2 years), 127 of 243 participants (mean age, 31.6 years) developed MS. Cox proportional-hazards models adjusted for established MRI criteria, age at onset, number of T1 lesions, and presence of CSF oligoclonal bands significantly predicted the risk of developing MS at 2 and 5 years. The use of multiple biomarkers led to 29% net reclassification improvement at 2 years (P Conclusions The simultaneous addition of several biomarkers significantly improved the risk stratification for MS in patients with CIS beyond that of a model based only on established MRI…

Integrity signals

Registry

Crossref · 10.1111/ane.12761

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a recent analysis, changing the requirement from one periventricular lesion to three improved specificity of DIS from 0.37 to 0.46 but decreased sensitivity from 0.88 to 0.83.

    “In a recent analysis, changing the requirement from one periventricular lesion to three improved specificity of DIS from 0.37 to 0.46 but decreased sensitivity from 0.88 to 0.83. 72”
  • The recent MAGNIMS analysis showed that adding optic nerve involvement detected by MRI or VEP as a fifth anatomic site led to a minor improvement in sensitivity from 0.88 to 0.91 but substantially reduced specificity from 0.52 from 0.41.

    “The recent MAGNIMS analysis showed that adding optic nerve involvement detected by MRI or VEP as a fifth anatomic site led to a minor improvement in sensitivity from 0.88 to 0.91 but substantially reduced specificity from 0.52 from 0.41. 72”
  • The analysis did not include OCT.

    “The analysis did not include OCT.”
  • The lesions detected by special MRI techniques for cortical lesions are primarily of the leukocortical type; subpial lesions are rarely detected.

    “The lesions detected by these techniques are primarily of the leukocortical type; subpial lesions are rarely detected.”

Cited by

Sorted by citations

Authors
Martinelli, V., Dalla Costa, G., Messina, M. J., Di Maggio, G., Sangalli, F., Moiola, L., Rodegher, M., Colombo, B., Furlan, R., Leocani, L., Falini, A., & Comi, G.
Affiliations
  • IRCCS Ospedale San Raffaele (IT)
  • Department of Neurology; San Raffaele Hospital; Milan Italy
  • IRCCS Policlinico San Donato (IT)
Corresponding author
Martinelli, V.
Venue
Acta Neurologica Scandinavica
Publisher
Wiley
Published
2017-04-09
Volume
136
Issue
5
Pages
454-461
ISSN
0001-6314 (ISSN-L)
OpenAlex
W2605244028
Cited by
27
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 2
FWCI
3.22
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Neurologica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Funders
Ministero della Salute (RF 2011-02349698)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
Keywords
multiple sclerosis, clinically isolated syndrome, biomarkers, risk prediction, MRI criteria, neurophysiological markers, net reclassification improvement, risk stratification, early diagnosis
MeSH terms
Adult, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Biomarkers, Proportional Hazards Models, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review